Filing Details

Accession Number:
0001209191-23-034803
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-06 17:11:38
Reporting Period:
2023-06-02
Accepted Time:
2023-06-06 17:11:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674930 Fulgent Genetics Inc. FLGT Services-Medical Laboratories (8071) 812621304
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1819718 Jian Xie C/O Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte CA 91731
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-02 1,433 $40.30 425,794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 220,816 Indirect By Trust
Footnotes
  1. The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.
  2. The shares were sold in multiple transactions at prices ranging from $39.79 to $40.75, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.